Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name GAS5
   Synonyms GAS5, NCRNA00030, SNHG2, ENST00000456293.5, GAS5-007
   Region GRCh38_1:173863900-173868882    Sequence
   Ensembl ENSG00000234741
   RefSeq NR_002578
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name cervical cancer
   ICD-0-3 C53  
   Methods qPCR, Western blot, RIP etc.
   Sample cervical cancer tissues, cell lines (SiHa, HT-3, SW756 and ME-180)
   Expression Pattern down-regulated
   Function Description

GAS5 expression was decreased in cervical cancer tissues and cells.GAS5 overexpression suppressed cervical cancer cell proliferation, invasion, and apoptosis. GAS5 was able to directly bind to miR-196a and miR-205 to downregulate their expression.Moreover, GAS5 induced forkhead box protein O1 and phosphatase and tensin homolog expression by repressing miR-196a and miR-205, respectively. Exogenous expression of GAS5 hindered tumor growth in vivo by downregulating miR-196a and miR-205. Upregulation of GAS5 suppressed cell proliferation, invasion, and apoptosis of cervical cancer cells by downregulating miR-196a and miR-205, contributing to our understanding the pathogenesis of cervical cancer and development of long non-coding RNA-mediated clinical therapy against this disease.

   Pubmed ID 28671039
   Year 2017
   Title LncRNA GAS5 suppresses the tumorigenesis of cervical cancer by downregulating miR-196a and miR-205.
   External Links
   Links for  GAS5 GenBank       HGNC       lncrnadb       Noncode
   Links for  cervical cancer Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.